Cargando…
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster()()
Recently, activating mutations of the hypoxia-inducible factor 2α gene (HIF2A/EPAS1) have been recognized to predispose to multiple paragangliomas (PGLs) and duodenal somatostatinomas associated with polycythemia, and ocular abnormalities. Previously, mutations in the SDHA/B/C/D, SDHAF2, VHL, FH, PH...
Autores principales: | Fliedner, Stephanie M.J., Shankavaram, Uma, Marzouca, Geena, Elkahloun, Abdel, Jochmanova, Ivana, Daerr, Roland, Linehan, W. Marston, Timmers, Henri, Tischler, Arthur S., Papaspyrou, Konstantinos, Brieger, Jürgen, de Krijger, Ronald, Breza, Jan, Eisenhofer, Graeme, Zhuang, Zhengping, Lehnert, Hendrik, Pacak, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031903/ https://www.ncbi.nlm.nih.gov/pubmed/27659016 http://dx.doi.org/10.1016/j.neo.2016.07.008 |
Ejemplares similares
-
Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
por: Fliedner, Stephanie M. J., et al.
Publicado: (2014) -
Warburg Effect’s Manifestation in Aggressive Pheochromocytomas and Paragangliomas: Insights from a Mouse Cell Model Applied to Human Tumor Tissue
por: Fliedner, Stephanie M. J., et al.
Publicado: (2012) -
The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
por: Wang, Yuxiong, et al.
Publicado: (2023) -
THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023) -
Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice
por: Bullova, Petra, et al.
Publicado: (2017)